课题基金 / 基金详情

Multiplexed Droplet Digital Nucleic Acid Amplification Technologies for HIV Diagnosis

Multiplexed Droplet Digital Nucleic Acid Amplification Technologies for HIV Diagnosis
用于 HIV 诊断的多重液滴数字核酸扩增技术
批准号:
10927089
负责人:
ROBIN PRINCE
金额:
$29.99万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
已结题
起止时间:
2023-08-01 至 2024-07-31

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
发展区分HIV感染和疫苗诱导的血清阳性的诊断学:该计划的总体目标是支持新的血清学和核酸分析的发展,这些方法可以识别HIV感染,同时避免由于疫苗诱导的血清阳性(VISP)而导致的假阳性结果,具有高度的敏感性和特异性。这些下一代检测方法应针对艾滋病毒检测的一个或所有应用/适应症,即:(1)基于实验室的检测;(2)护理点和临床实践;以及(3)自我检测。这份合同旨在开发一种液滴数字核酸测试来诊断艾滋病毒感染。
英文摘要
Development of Diagnostics to Differentiate HIV Infection from Vaccine-Induced Seropositivity: The overarching goal of this program is to support the development of new serological and nucleic acid assays that can identify HIV infection while avoiding false-positive results due to vaccine-induced seropositivity (VISP), with high sensitivity and specificity. These next generation assays should be developed to address one or all applications/indications of HIV tests, namely: (1) laboratory based tests; ((2) point-of-care and clinical practices; and (3) self-testing. This contract aims to develop a droplet digital nucleic acid test to diagnose HIV infection.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金